RS Technologies (3445) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
26 Oct, 2026Executive summary
Q1 FY2024 net sales rose 26.4% YoY to ¥15.36bn, while operating income fell 12.6% to ¥2.63bn; parent-attributable net income increased 4.5% to ¥1.78bn.
Comprehensive income rose 54.3% YoY to ¥7.07bn, supported by higher foreign currency translation adjustments.
Financial highlights
Ordinary income was ¥3.59bn, down 1.3% YoY.
EPS was ¥67.60 vs ¥64.87 YoY; diluted EPS was ¥67.23 vs ¥64.53.
Outlook and guidance
FY2024 guidance: net sales ¥54.9bn, operating income ¥14.0bn, ordinary income ¥15.4bn and parent-attributable net income ¥7.6bn.
H1 guidance: net sales ¥26.5bn, operating income ¥6.5bn, ordinary income ¥7.3bn and parent-attributable net income ¥3.7bn; H1 EPS guidance is ¥140.37.
FY2024 EPS guidance is ¥288.34.
Base-plan FY2026 targets: net sales ¥64.1bn, operating income ¥16.83bn and net income ¥8.8bn.
Upside-plan FY2026 target is ¥131.1bn in net sales, including ¥24bn targeted LE System sales and ~¥43bn of M&A sales growth over three years.
Latest events from RS Technologies
- Prime wafers led 9M growth as reclaim and VRFB capacity expanded.3445
Q3 2026 - H1 revenue rose 15.1%, but operating income fell 4.9%; FY guidance was unchanged.3445
Q2 2024 - 9M sales rose 12.8%, led by reclaimed wafers; FY2026 upside sales target: ¥131.1bn.3445
Q3 2024 - Record FY2024 growth; FY2025 revenue guidance rises as net income is forecast lower.3445
Q4 2024 - H1 sales and operating income grew, but FX and translation effects weighed on earnings.3445
Q2 2025 - Wafer growth lifted sales and operating income, while comprehensive income swung to a loss.3445
Q1 2025 - 9M sales rose 31.5%, while prime wafer pricing pressure contrasted with expansion plans.3445
Q3 2025 - Record FY2025 results support reclaimed-wafer expansion and FY2028 growth targets.3445
Q4 2025 - Q1 earnings rose as reclaimed-wafer growth and currency gains lifted results.3445
Q1 2026